Inside the research

Elevance Health, Inc.

ELV Research profile · latest available data

Price overview

$396.09

▼ -2.16 (-0.5%)

52w hi$424.94
52w lo$276.68
Vol1.22M
As of25 Sep 2026

The Verdict

Hold

Our score +0.31

Short+0.33
Medium+0.41
Long+0.07

computed 2026-09-27

Key fundamentals

Elevance Health, Inc.

Healthcare · Healthcare Plans

Market cap$85.90B
Enterprise value$79.57B
Trailing P/E17.51x
Forward P/E13.41x
EV / EBITDA9.56x
P / S (ttm)0.43x
Profit margin2.5%
Return on equity11.1%
Revenue growth+1.4%
Earnings growth-13.1%
Debt / equity68.95

Layer Breakdown

LayerRawContribution
Fundamental+0.12
Sector+0.08
Technical+0.25
Earnings+0.00
Sentiment-0.00

macro × 1.00 · 2026-09-27

Business overview

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

United States · www.elevancehealth.com

Risk Metrics

Beta vs SPX0.24
Corr SPX0.11
Annual vol36.0%
Annual ret-8.9%
Sharpe-0.25
Max DD-48.6%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$388.95
High / Low$474.00 / $331.00
Median$391.00
Analysts21
Strong Buy3
Buy11
Hold8
Sell0
Strong Sell0

Recent rating actions

2026-04-29B of A Securities→ Buy
2026-04-28JP Morgan→ Overweight
2026-04-24Guggenheim→ Buy
2026-04-24Barclays→ Overweight
2026-04-23Evercore ISI Group→ In-Line
2026-04-23Baird→ Neutral

Material Events

DateEvent8-K
2026-07-15Earnings Release, Exhibitsread
2026-06-10Reg FD Disclosureread
2026-05-13Shareholder Voteread
2026-04-22Earnings Release, Exhibitsread
2026-03-10Reg FD Disclosureread
2026-03-02Other Material Eventread
2026-02-26Officer / Director Change, Reg FD Disclosureread
2026-01-28Earnings Release, Exhibitsread
2025-12-10Officer / Director Changeread
2025-11-10Reg FD Disclosureread
2025-10-21Earnings Release, Exhibitsread
2025-09-15Other Material Event, Exhibitsread

Insider Trades

DateInsiderRoleActionSharesValue
2026-07-17PERU RAMIRO GBuy1.00K$366.05K
2026-07-17BOUDREAUX GAILPresident and CEOBuy680$249.16K
2026-07-17BOUDREAUX GAILPresident and CEOBuy2.04K$753.07K
2026-06-12Penczek Ronald WCAO & ControllerSell369$148.77K
2026-06-11Dixon Robert L JRSell151$60.67K
2026-05-19Penczek Ronald WCAO & ControllerOption exercise654$177.41K
2026-05-19Penczek Ronald WCAO & ControllerSell1.53K$617.19K
2026-05-19Penczek Ronald WCAO & ControllerOption exercise877$273.17K
2026-05-13SCHULMAN AMY WGrant563—
2026-05-13Schneider Ryan M.Grant563—

Flow & Concentration

Insider 180d net$541.65K
Insider buys / sells3 / 3
Insider biasNeutral
13F holders1
Top-5 share100.0%
HHI10,000 (concentrated)

Top Holders

HolderValueShares
BlackRock Inc$11.22B20.70M

As of 2024-06-30

Connections

Subsidiarys: Carelon Global Solutions (BPO/Shared Services subsidiary)

Dividends

Yield (TTM)0.87%
$ / share (TTM)$3.43
5y CAGR+12.5%

Annual dividend per share

2021$4.52
2022$5.12
2023$5.92
2024$6.52
2025$6.84
2026$1.72

SEC Filings

DateFormDoc
2026-07-174view
2026-07-174view
2026-07-1510-Qview
2026-07-158-Kview
2026-06-1711-Kview
2026-06-1711-Kview
2026-06-154view
2026-06-124view
2026-06-108-Kview
2026-05-204view
2026-05-154view
2026-05-154view
2026-05-154view
2026-05-154view
2026-05-154view

The Long Run

FY 2009–2025 · 16 years

LineLatestCAGRTrend
Revenue$177.01B+7.3%
Operating income$8.50B+4.9%
Net income$5.66B+1.2%
Cash from ops$8.06B+4.2%

Indices

S&P 500

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$400.00$405.13$394.69$396.091.22M
Sep 24$397.00$400.97$394.31$398.251.17M
Sep 23$400.84$404.39$396.37$398.561.21M
Sep 22$412.07$412.75$401.38$402.431.12M
Sep 21$410.31$411.48$406.20$409.31934.00K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →